CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(03): E301-E309
DOI: 10.1055/a-1090-7200
Original article

Outcomes of gastrointestinal bleeding in patients with left ventricular assist devices: a tertiary care experience

Caren Taylor
1   Center for Advanced Therapeutic Endoscopy, Division of Gastroenterology & Hepatology, University of Rochester Medical Center, Rochester New York, United States
,
Krystle Bittner
1   Center for Advanced Therapeutic Endoscopy, Division of Gastroenterology & Hepatology, University of Rochester Medical Center, Rochester New York, United States
,
Nicholas Bartell
1   Center for Advanced Therapeutic Endoscopy, Division of Gastroenterology & Hepatology, University of Rochester Medical Center, Rochester New York, United States
,
Jose Aranez
1   Center for Advanced Therapeutic Endoscopy, Division of Gastroenterology & Hepatology, University of Rochester Medical Center, Rochester New York, United States
,
Jeffrey D Alexis
2   Division of Cardiology, University of Rochester Medical Center, Rochester New York, United States
,
Beth Carlson
2   Division of Cardiology, University of Rochester Medical Center, Rochester New York, United States
,
Leway Chen
2   Division of Cardiology, University of Rochester Medical Center, Rochester New York, United States
,
Scott McNitt
2   Division of Cardiology, University of Rochester Medical Center, Rochester New York, United States
,
Truptesh Kothari
1   Center for Advanced Therapeutic Endoscopy, Division of Gastroenterology & Hepatology, University of Rochester Medical Center, Rochester New York, United States
,
Vivek Kaul
1   Center for Advanced Therapeutic Endoscopy, Division of Gastroenterology & Hepatology, University of Rochester Medical Center, Rochester New York, United States
,
Shivangi Kothari
1   Center for Advanced Therapeutic Endoscopy, Division of Gastroenterology & Hepatology, University of Rochester Medical Center, Rochester New York, United States
› Author Affiliations

Abstract

Background and study aims Left ventricular assist device (LVAD) placement is a therapeutic modality for patients with end-stage heart failure. Gastrointestinal bleeding is a common complication following LVAD implantation. The aim of this study was to report our experience in management and outcomes of gastrointestinal bleeding in a large cohort of patients with LVADs.

Patients and methods We performed a retrospective review of all patients who underwent LVAD implantation at the University of Rochester Medical Center from January 2008 to June 2017. Data were collected on patient characteristics, clinical aspects of gastrointestinal bleeding events, and procedural interventions. A Cox proportional hazard model was utilized to identify potential risk factors for a gastrointestinal bleeding event.

Results During the study period, 345 patients underwent LVAD implantation. Of these, 125 patients (36.2 %) experienced 297 gastrointestinal bleeding events resulting in 533 endoscopic procedures. The diagnostic yield of endoscopy in determining a bleeding source was 49.5 %. If required, therapeutic interventions were successful in achieving homeostasis in 96.2 % of procedures. Our 30-day overall post-procedure adverse event (AE) rate was 6.6 %. Procedure-related (bleeding, infection, and perforation) AEs were very minimal (2.8 %). A Cox proportional hazard model indicated that older age at implant, female sex, African-American race, diabetes mellitus, and pulmonary hypertension were statistically significant predictors of a gastrointestinal bleeding event following LVAD implantation.

Conclusions LVAD patients have a high risk of gastrointestinal bleeding. Endoscopy was able to safely locate a bleeding lesion in approximately half of our patients and was successful in treating bleeding lesions in a majority of the cases.



Publication History

Received: 18 April 2019

Accepted: 28 October 2019

Article published online:
21 February 2020

© 2020. Owner and Copyright ©

© Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Mozaffarian D, Benjamin EJ, Go AS. et al. Heart disease and stroke statistics-2016 update. A report from the American Heart Association. Circulation 2016; 133: e38-e360
  • 2 Heidenreich PA, Albert NM, Allen LA. et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 2013; 6: 606-619
  • 3 Kirklin JK, Pagani FD, Kormos RL. et al. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant 2017; 36: 1080-1086
  • 4 Crow S, John R, Boyle A. et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009; 137: 208-215
  • 5 Islam S, Cevik C, Madonna R. et al. Left ventricular assist devices and gastrointestinal bleeding: a narrative review of case reports and case series. Clin Cardiol 2013; 36: 190-200
  • 6 Draper KV, Huang RJ, Gerson LB. GI bleeding in patients with continuous-flow left ventricular assist devices: A systematic review and meta-analysis. Gastrointest Endosc 2014; 80: 435-446.e1
  • 7 Aggarwal A, Pant R, Kumar S. et al. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg 2012; 93: 1534-1540
  • 8 Morgan JA, Paone G, Nemeh HW. et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2012; 31: 715-718
  • 9 Demirozu ZT, Radovancevic R, Hochman LF. et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2011; 30: 849-853
  • 10 Goldstein DJ, Aaronson KD, Tatooles AJ. et al. Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System. JACC Heart Fail 2015; 3: 303-313
  • 11 Guha A, Eshelbrenner CL, Richards DM. et al. Gastrointestinal Bleeding After Continuous-flow Left Ventricular Device Implantation: Review of Pathophysiology and Management. Methodist Debakey Cardiovasc J 2015; 11: 24-27
  • 12 Heyde EC. Gastrointestinal bleeding in aortic stenosis. N Engl J Med 1958; 259: 196
  • 13 Letsou GV, Shah N, Gregoric ID. et al. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005; 24: 105-109
  • 14 Baldauf C, Schneppenheim R, Stacklies W. et al. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis. J Thromb Haemost 2009; 7: 2096-2105
  • 15 Uriel N, Pak SW, Jorde UP. et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010; 56: 1207-1213
  • 16 Shrode CW, Draper KV, Huang RJ. et al. Significantly higher rates of gastrointestinal bleeding and thromboembolic events with left ventricular assist devices. Clin Gastroenterol Hepatol 2014; 12: 1461-1467
  • 17 Stern DR, Kazam J, Edwards P. et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg 2010; 25: 352-356
  • 18 Kushnir VM, Sharma S, Ewald GA. et al. Evaluation of GI bleeding after implantation of left ventricular assist device. Gastrointest Endosc 2012; 75: 973-979
  • 19 Demirozu ZT, Radovancevic R, Hochman LF. et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2011; 30: 849-853
  • 20 Aggarwal A, Pant R, Kumar S. et al. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg 2012; 93: 1534-1540
  • 21 Morgan JA, Panone G, Nemeh HW. et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2012; 31: 715-718
  • 22 Sparrow CT, Nassif ME, Raymer DS. et al. Pre-operative right ventricular dysfunction is associated with gastrointestinal bleeding in patients supported with continuous-flow left ventricular assist devices. JACC Heart Fail 2015; 3: 956-964
  • 23 Jabbar HR, Abbas A, Ahmed M. et al. The incidence, predictors and outcomes of gastrointestinal bleeding in patients with left ventricular assist device (LVAD). Dig Dis Sci 2015; 60: 3697-3706
  • 24 Guha A, Eshelbrenner CL, Richards DM. et al. Gastrointestinal bleeding after continuous-flow left ventricular assist device implantation: Review of pathophysiology and management. Methodist Debakey Cardiovasc J 2015; 11: 24-27
  • 25 Marsano J, Desai J, Chang S. et al. Characteristics of gastrointestinal bleeding after placement of continuous-flow left ventricular assist device: A case series. Dig Dis Sci 2015; 60: 1859-1867
  • 26 Tarzia V, Dal Lin C, Bottio T. et al. Occult gastrointestinal bleeding in patients with a left ventricular assist device axial flow pump: Diagnostic tools and therapeutic algorithm. J Thorac Cardiovasc Surg 2012; 143: e28-e31
  • 27 Elmunzer BJ, Padhya KT, Lewis JJ. et al. Endoscopic findings and clinical outcomes in ventricular assist device recipients with gastrointestinal bleeding. Dig Dis Sci 2011; 56: 3241-3246
  • 28 Axelrad JE, Pinsino A, Trinh PN. et al. Limited usefulness of endoscopic evaluation in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding. J Heart Lung Transplant 2018; 37: 723-732
  • 29 Schulze PC, Kitada S, Clerkin K. et al. Regional differences in recipient waitlist time and pre- and post- transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart allocation program. JACC Heart Fail 2014; 2: 166-177
  • 30 Kushnir VM, Sharma S, Ewald GA. et al. Evaluation of GI Bleeding after implantation of left ventricular assist device. Gastrointest Endosc 2012; DOI: 10.1016/j.gie.2011.12.014.
  • 31 Sarosiek K, Bogar L, Conn MI. et al. An old problem with a new therapy: gastrointestinal bleeding in ventricular assist device patients and deep overtube-assisted enteroscopy. ASAIO J 2013; 59: 384-389
  • 32 Cushing K, Kushnir V. Gastrointestinal bleeding following LVAD placement from top to bottom. Dig Dis Sci 2016; 61: 1440-1447
  • 33 Guha A, Eshelbrenner CL, Richards DM. et al. Gastrointestinal bleeding after continuous-flow left ventricular device implantation: Review of pathophysiology and management. Methodist Debakey Cardiovascular J 2015; 11: 24-27
  • 34 Thoban V, Shi Y, Rappelt M. et al. The association of novel clinical factors and gastrointestinal bleeding among patients supported with continuous-flow left ventricular assist device therapy. J Card Surg 2019; DOI: 10.1111/jdocs.14062.
  • 35 Yin MY, Ruckel S, Kfoury AG. et al. Novel model to predict gastrointestinal bleeding during left ventricular device support. Circ Heart Fail 2018; 11: e005267